Home »
RECENT NEWS

Visit the WFH News page to find out more about the events and developments that are making a difference today.

WFH Humanitarian Aid Program Impact Report 2024 released

WFH Humanitarian Aid Program Impact Report 2024 released

The WFH Humanitarian Aid Program Impact Report 2024 is now available! The report shows that 2024 was another productive year for the Program, as it continued to support countries by providing them with predictable treatment product donations, education, training, and government lobbying assistance.

Also available in: Français Español

Thanks to many generous sponsors, the WFH Humanitarian Aid Program was able to change lives for the better. In 2024, the Program celebrated a major milestone: the 10-year anniversary of Sanofi and Sobi answering the WFH call to action, which urged manufacturers to support the global inherited bleeding disorders community through the donation of treatment products and financial aid to the WFH Humanitarian Aid Program.

The Program supports countries around the world with one objective in mind: to help countries along their journey to sustainability in inherited bleeding disorders care.

In 2024, life-changing support was once again delivered to those who need it most:

All of these successes were made possible by the dedication of our volunteers, staff and the commitment of our partners: WFH national member organizations (NMOs), hemophilia treatment centres (HTCs), healthcare professionals (HCPs), governments, donors, members of the WFH and WFH USA boards, and our global inherited bleeding disorders community.

To read the WFH Humanitarian Aid Program Impact Report 2024, click here. To find out more about the WFH Humanitarian Aid Program, click here.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and Takeda, our Contributor. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?